2-151618284-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4BP7BS1
This summary comes from the ClinGen Evidence Repository: The c.11067C>T is a synonymous (silent) variant (p.Asn3689=) that is not predicted by SpliceAI to impact splicing. In addition, it occurs at a nucleotide that is not conserved as shown by the UCSC Genome Browser (BP4, BP7). The highest population filtering allele frequency in gnomAD v4.1.0 is 0.0006878 (922/1461502 alleles, 2 homozygotes) in the non-Finnish European population, which is higher than the ClinGen Congenital Myopathies VCEP threshold (MAF ≥ 0.000237) for BS1, and therefore meets this criterion (BS1). In summary, this variant meets the criteria to be classified as likely benign for autosomal recessive congenital myopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen Congenital Myopathy VCEP: BS1, BP4, BP7. (Congenital Myopathies VCEP specifications version 1; 8/7/2024) LINK:https://erepo.genome.network/evrepo/ui/classification/CA1908888/MONDO:0018958/146
Frequency
Consequence
NM_001164508.2 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEB | ENST00000397345.8 | c.11067C>T | p.Asn3689Asn | synonymous_variant | 74/182 | 5 | NM_001164508.2 | ENSP00000380505.3 | ||
NEB | ENST00000427231.7 | c.11067C>T | p.Asn3689Asn | synonymous_variant | 74/182 | 5 | NM_001164507.2 | ENSP00000416578.2 | ||
NEB | ENST00000409198.5 | c.10338C>T | p.Asn3446Asn | synonymous_variant | 71/150 | 5 | ENSP00000386259.1 |
Frequencies
GnomAD3 genomes AF: 0.000427 AC: 65AN: 152172Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000450 AC: 112AN: 248706Hom.: 0 AF XY: 0.000511 AC XY: 69AN XY: 134914
GnomAD4 exome AF: 0.000631 AC: 922AN: 1461502Hom.: 2 Cov.: 31 AF XY: 0.000615 AC XY: 447AN XY: 727072
GnomAD4 genome AF: 0.000427 AC: 65AN: 152172Hom.: 0 Cov.: 32 AF XY: 0.000538 AC XY: 40AN XY: 74332
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 22, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | NEB: BP4, BP7 - |
NEB-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 15, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Nemaline myopathy Benign:1
Likely benign, reviewed by expert panel | curation | ClinGen Congenital Myopathies Variant Curation Expert Panel, ClinGen | Aug 07, 2024 | The c.11067C>T is a synonymous (silent) variant (p.Asn3689=) that is not predicted by SpliceAI to impact splicing. In addition, it occurs at a nucleotide that is not conserved as shown by the UCSC Genome Browser (BP4, BP7). The highest population filtering allele frequency in gnomAD v4.1.0 is 0.0006878 (922/1461502 alleles, 2 homozygotes) in the non-Finnish European population, which is higher than the ClinGen Congenital Myopathies VCEP threshold (MAF ≥ 0.000237) for BS1, and therefore meets this criterion (BS1). In summary, this variant meets the criteria to be classified as likely benign for autosomal recessive congenital myopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen Congenital Myopathy VCEP: BS1, BP4, BP7. (Congenital Myopathies VCEP specifications version 1; 8/7/2024) - |
Nemaline myopathy 2 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at